Loading...
Towards the prevention of potential aluminum toxic effects and an effective treatment for Alzheimer’s disease
In 1991, treatment with low dose intramuscular desferrioxamine (DFO), a trivalent chelator that can remove excessive iron and/or aluminum from the body, was reported to slow the progression of Alzheimer’s disease (AD) by a factor of two. Twenty years later this promising trial has not been followed...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3714848/ https://ncbi.nlm.nih.gov/pubmed/22099160 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jinorgbio.2011.08.001 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|